← Evidence map

ArticleBlood advances2025

Use of Affimer technology for inhibition of α2-antiplasmin and enhancement of fibrinolysis.

Nikoletta Pechlivani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39504559